NASDAQ$ESTA

Establishment Labs Holdings Inc · Q2 2024 earnings

Q2 2024 earnings · · Investor relations

Briefing

Reported strong sequential revenue growth and improved adjusted EBITDA.

Establishment Labs reported a decrease in revenue for the second quarter of 2024, with $44.1 million compared to $48.6 million in the same period of 2023. However, the company saw an improvement in gross profit margin and a reduction in operating expenses, leading to a smaller loss from operations and an improved adjusted EBITDA loss. The company is awaiting FDA approval of Motiva Implants.

  • Second quarter worldwide revenue was $44.1 million.
  • Gross profit for the second quarter was $28.9 million, or 65.6% of revenue.
  • Second quarter loss from operations was $9.3 million.
  • Cash balance of $54.6 million as of June 30, 2024.

Headline financials

Total Revenue

$44.1M

Previous: $48.6M-9.2%
EPS

-$0.62

Previous: -$0.65+4.6%
Gross Margin

65.6%

No prior period
Quarterly Cash Increase

$18.4M

No prior period
Capital Expenditures

-$4.11M

Previous: -$3.55M-15.8%
Free Cash Flow

-$21.3M

Previous: -$20.3M-4.9%
Net Income

-$17.2M

Previous: -$16.7M-2.6%
Operating Income

-$9.34M

Previous: -$13.7M+31.9%
Gross Profit

$28.9M

Previous: $30.3M-4.4%
Cash & Equivalents

$56.1M

Previous: $90.2M-37.8%
Total Assets

$285M

Previous: $285M-0.1%
R&D Expense

$5.49M

No prior period
Stock-Based Comp

$3.76M

Previous: $3.62M+3.9%

Revenue & EPS history

Establishment Labs · Revenue · Quarterly

$44.1M

Q2 2024-9.2%vs Q2 2023
Beat estimate in 13 of 15 quarters(87%)
ActualEstimate

Forward guidance

The company's 2024 revenue guidance remains $174 million to $184 million, an increase of 5% to 11% over 2023.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2024

Historical avgQ2 2024

+1.5%

Avg return

Earnings day

+0.7%

Avg return

5 days after

+2.4%

Avg return

30 days after

56%

18 / 32 earnings

Positive

+22.5%

Q3 2025

Best reaction

-26.0%

Q3 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-0.4%-4.3%+2.9%
Q4 2025-1.9%+5.0%-20.1%
Q3 2025+22.5%+37.0%+43.2%
Q1 2025+4.9%+5.1%+14.2%
Q4 2024+17.9%+28.1%+12.1%
Q3 2024-5.2%-13.2%-10.0%
Q2 2024+3.4%+20.6%+23.5%
Q1 2024+5.4%+4.2%-10.8%
Q4 2023+15.1%+19.6%+28.2%
Q3 2023-26.0%-36.1%-31.7%
Q2 2023-8.4%-12.0%-12.2%
Q1 2023+1.8%-1.6%-1.9%
Q4 2022+7.2%+10.3%+0.3%
Q3 2022-7.7%+11.1%+27.1%
Q2 2022-3.0%+1.3%-0.4%
Q1 2022-10.5%-10.1%+2.3%
Q4 2021+3.3%+1.6%+11.5%
Q3 2021-10.6%-14.3%-15.2%
Q2 2021+6.0%-3.7%-3.1%
Q1 2021-0.6%-1.8%+8.9%
Q4 2020+0.4%-6.8%+9.5%
Q3 2020+8.9%-0.4%+22.6%
Q2 2020+6.2%+7.3%+9.3%
Q1 2020+2.9%+0.5%+15.3%
Q4 2019+4.5%-16.4%+0.4%
Q3 2019-0.3%+0.5%+7.8%
Q2 2019-5.2%-10.6%-10.2%
Q1 2019+1.5%-0.3%-15.9%
Q4 2018-1.9%-4.9%-15.2%
Q3 2017+10.3%+4.5%-6.2%
Q3 2018+10.3%+4.5%-6.2%
Q2 2018-2.7%-2.9%-3.4%
Q4 2017
Q2 2017
Q1 2017

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro